Physiology and therapeutics of the free fatty acid receptor GPR40

Progress in Molecular Biology and Translational Science

Volumn 121, Issue , 2014, Pages 67-94

  Huang, Hui ^a   Dai, Meng Hong ^a,b   Tao, Ya Xiong ^a  

^a AUBURN UNIVERSITY   (United States)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

FFA; GPCR; GPR40; T2DM

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; AM 1638; AMG 837; ARACHIDONIC ACID; BETA FUNALTREXAMINE; CNX 011 67; DC 260126; EPIDERMAL GROWTH FACTOR RECEPTOR; FASIGLIFAM; FATTY ACID; G PROTEIN COUPLED RECEPTOR 120; G PROTEIN COUPLED RECEPTOR 40; G PROTEIN COUPLED RECEPTOR 40 AGONIST; G PROTEIN COUPLED RECEPTOR 40 ANTAGONIST; GLIMEPIRIDE; GLUCAGON; GLUCOSE; GW 1100; GW 9508; INCRETIN; INSULIN; MU OPIATE RECEPTOR ANTAGONIST; OLEIC ACID; ORAL ANTIDIABETIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; PHOSPHOLIPID; RECEPTOR BLOCKING AGENT; TUG 770; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AGONIST; ANTINOCICEPTION; ARTICLE; ATOPIC DERMATITIS; BONE DENSITY; CELL PROLIFERATION; CONTACT ALLERGY; DOSE RESPONSE; DRUG EFFECT; EAR EDEMA; GLUCAGON RELEASE; GLYCEMIC CONTROL; HORMONE RELEASE; HUMAN; HYPOGLYCEMIA; INFLAMMATION; INSULIN RELEASE; LIGAND BINDING; MOLECULAR CLONING; NERVOUS SYSTEM DEVELOPMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOPOROSIS; PAIN; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TASTE PREFERENCE; TISSUE DISTRIBUTION;

FFA; GPCR; GPR40; T2DM;

AMINO ACID SEQUENCE; ANIMALS; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION PROFILING; HUMANS; MOLECULAR SEQUENCE DATA; MOLECULAR TARGETED THERAPY; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84896696014     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800101-1.00003-X     Document Type: Chapter

References (106)

1. G. Boden, and G.I. Shulman Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction Eur J Clin Invest 32 2002 14 23
2. S.R. Crespin, W.B. Greenough, and D. Steinberg Stimulation of insulin secretion by infusion of free fatty acids J Clin Invest 48 1969 1934 1943
3. D.T. Stein, V. Esser, and B.E. Stevenson et al. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat J Clin Invest 97 1996 2728 2735
4. G. Boden, X.H. Chen, and N. Iqbal Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects Diabetes 47 1998 1609 1612
5. D.T. Stein, B.E. Stevenson, and M.W. Chester et al. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation J Clin Invest 100 1997 398 403
6. V. Poitout, J. Amyot, M. Semache, B. Zarrouki, D. Hagman, and G. Fontes Glucolipotoxicity of the pancreatic beta cell Biochim Biophys Acta 1801 2010 289 298
7. R.N. Bergman, and M. Ader Free fatty acids and pathogenesis of type 2 diabetes mellitus Trends Endocrinol Metab 11 2000 351 356
8. C.J. Nolan, M.S. Madiraju, V. Delghingaro-Augusto, M.L. Peyot, and M. Prentki Fatty acid signaling in the β-cell and insulin secretion Diabetes 55 Suppl 2 2006 S16 S23
9. Y. Itoh, Y. Kawamata, and M. Harada et al. Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40 Nature 422 2003 173 176
10. M. Sawzdargo, S.R. George, T. Nguyen, S. Xu, L.F. Kolakowski, and B.F. O'Dowd A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1 Biochem Biophys Res Commun 239 1997 543 547
11. C.P. Briscoe, M. Tadayyon, and J.L. Andrews et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids J Biol Chem 278 2003 11303 11311
12. K. Kotarsky, N.E. Nilsson, B. Olde, and C. Owman Progress in methodology. Improved reporter gene assays used to identify ligands acting on orphan seven-transmembrane receptors Pharmacol Toxicol 93 2003 249 258
13. V. Vangaveti, V. Shashidhar, G. Jarrod, B.T. Baune, and R.L. Kennedy Free fatty acid receptors: emerging targets for treatment of diabetes and its complications Ther Adv Endocrinol Metab 1 2010 165 175
14. A.J. Brown, S. Jupe, and C.P. Briscoe A family of fatty acid binding receptors DNA Cell Biol 24 2005 54 61
15. R. Fredriksson, P.J. Hoglund, D.E.I. Gloriam, M.C. Lagerstrom, and H.B. Schioth Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives FEBS Lett 554 2003 381 388
16. A. Salehi, E. Flodgren, and N.E. Nilsson et al. Free fatty acid receptor 1 (FFA(1)R/GPR40) and its involvement in fatty-acid-stimulated insulin secretion Cell Tissue Res 322 2005 207 215
17. + currents in primary cultured rat pancreatic β-cells by linoleic acids Endocrinology 147 2006 674 682
18. T. Tomita, H. Masuzaki, and M. Noguchi et al. GPR40 gene expression in human pancreas and insulinoma Biochem Biophys Res Commun 338 2005 1788 1790
19. S. Odori, K. Hosoda, and T. Tomita et al. GPR119 expression in normal human tissues and islet cell tumors: evidence for its islet-gastrointestinal distribution, expression in pancreatic beta and alpha cells, and involvement in islet function Metabolism 62 2013 70 78
20. D. Ma, B. Tao, and S. Warashina et al. Expression of free fatty acid receptor GPR40 in the central nervous system of adult monkeys Neurosci Res 58 2007 394 401
21. D. Ma, L. Lu, and N.B. Boneva et al. Expression of free fatty acid receptor GPR40 in the neurogenic niche of adult monkey hippocampus Hippocampus 18 2008 326 333
22. J.C. Honore, A. Kooli, and D. Hamel et al. Fatty acid receptor Gpr40 mediates neuromicrovascular degeneration induced by transarachidonic acids in rodents Arterioscler Thromb Vasc Biol 33 2013 954 961
23. J.I. Miyazaki, K. Araki, and E. Yamato et al. Establishment of a pancreatic β-cell line that retains glucose-inducible insulin-secretion: special reference to expression of glucose transporter isoforms Endocrinology 127 1990 126 132
24. H. Shapiro, S. Shachar, I. Sekler, M. Hershfinkel, and M.D. Walker Role of GPR40 in fatty acid action on the β cell line INS-1E Biochem Biophys Res Commun 335 2005 97 104
25. E. Flodgren, B. Olde, S. Meidute-Abaraviciene, M.S. Winzell, B. Ahren, and A. Salehi GPR40 is expressed in glucagon producing cells and affects glucagon secretion Biochem Biophys Res Commun 354 2007 240 245
26. A. Hirasawa, C. Itsubo, and K. Sadakane et al. Production and characterization of a monoclonal antibody against GPR40 (FFAR1; free fatty acid receptor 1) Biochem Biophys Res Commun 365 2008 22 28
27. 2 +]i increase in pancreatic islet α-cells J Endocrinol 210 2011 173 179
28. S. Edfalk, P. Steneberg, and H. Edlund Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion Diabetes 57 2008 2280 2287
29. H.E. Parker, A.M. Habib, G.J. Rogers, F.M. Gribble, and F. Reimann Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells Diabetologia 52 2009 289 298
30. A.P. Liou, X. Lu, and Y. Sei et al. The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin Gastroenterology 140 2011 903 912
31. J. Cornish, A. MacGibbon, and J.M. Lin et al. Modulation of osteoclastogenesis by fatty acids Endocrinology 149 2008 5688 5695
32. A. Mieczkowska, M.F. Basle, D. Chappard, and G. Mabilleau Thiazolidinediones induce osteocyte apoptosis by a G protein-coupled receptor 40-dependent mechanism J Biol Chem 287 2012 23517 23526
33. F. Wauquier, C. Philippe, and L. Leotoing et al. The free fatty acid receptor G protein-coupled receptor 40 (GPR40) protects from bone loss through inhibition of osteoclast differentiation J Biol Chem 288 2013 6542 6551
34. T. Yonezawa, K. Katoh, and Y. Obara Existence of GPR40 functioning in a human breast cancer cell line, MCF-7 Biochem Biophys Res Commun 314 2004 805 809
35. S. Hardy, G.G. St-Onge, E. Joly, Y. Langelier, and M. Prentki Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40 J Biol Chem 280 2005 13285 13291
36. C.P. Briscoe, A.J. Peat, and S.C. McKeown et al. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules Br J Pharmacol 148 2006 619 628
37. R. Brownlie, R.M. Mayers, J.A. Pierce, A.E. Marley, and D.M. Smith The long-chain fatty acid receptor, GPR40, and glucolipotoxicity: investigations using GPR40-knockout mice Biochem Soc Trans 36 2008 950 954
38. P. Steneberg, N. Rubins, R. Bartoov-Shifman, M.D. Walker, and H. Edlund The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse Cell Metab 1 2005 245 258
39. M.G. Latour, T. Alquier, and E. Oseid et al. GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo Diabetes 56 2007 1087 1094
40. H. Lan, L.M. Hoos, and L. Liu et al. Lack of FFAR1/GPR40 does not protect mice from high-fat diet-induced metabolic disease Diabetes 57 2008 2999 3006
41. T. Alquier, M.L. Peyot, and M.G. Latour et al. Deletion of GPR40 impairs glucose-induced insulin secretion in vivo in mice without affecting intracellular fuel metabolism in islets Diabetes 58 2009 2607 2615
42. M. Kebede, T. Alquier, M.G. Latour, M. Semache, C. Tremblay, and V. Poitout The fatty acid receptor GPR40 plays a role in insulin secretion in vivo after high-fat feeding Diabetes 57 2008 2432 2437
43. K. Nagasumi, R. Esaki, and K. Iwachidow et al. Overexpression of GPR40 in pancreatic β-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice Diabetes 58 2009 1067 1076
44. X. Zhang, G. Yan, Y. Li, W. Zhu, and H. Wang DC260126, a small-molecule antagonist of GPR40, improves insulin tolerance but not glucose tolerance in obese Zucker rats Biomed Pharmacother 64 2010 647 651
45. L.S. Doshi, M.K. Brahma, and S.G. Sayyed et al. Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in the rat Metabolism 58 2009 333 343
46. D.C. Lin, J. Zhang, and R. Zhuang et al. AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents PLoS One 6 2011 e27270
47. S. Sasaki, S. Kitamura, and N. Negoro et al. Design, synthesis, and biological activity of potent and orally available G protein-coupled receptor 40 agonists J Med Chem 54 2011 1365 1378
48. Y. Tsujihata, R. Ito, and M. Suzuki et al. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats J Pharmacol Exp Ther 339 2011 228 237
49. J.B. Houze, L. Zhu, and Y. Sun et al. AMG 837: a potent, orally bioavailable GPR40 agonist Bioorg Med Chem Lett 22 2012 1267 1270
50. J. Luo, G. Swaminath, and S.P. Brown et al. A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodents PLoS One 7 2012 e46300
51. S. Mikami, S. Kitamura, and N. Negoro et al. Discovery of phenylpropanoic acid derivatives containing polar functionalities as potent and orally bioavailable G protein-coupled receptor 40 agonists for the treatment of type 2 diabetes J Med Chem 55 2012 3756 3776
52. N. Negoro, S. Sasaki, and M. Ito et al. Identification of fused-ring alkanoic acids with improved pharmacokinetic profiles that act as G protein-coupled receptor 40/free fatty acid receptor 1 agonists J Med Chem 55 2012 1538 1552
53. E. Christiansen, S.V. Hansen, and C. Urban et al. Discovery of TUG-770: a highly potent free fatty acid receptor 1 (FFA1/GPR40) agonist for treatment of type 2 diabetes ACS Med Chem Lett 4 2013 441 445
54. C.F. Burant, P. Viswanathan, and J. Marcinak et al. TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial Lancet 379 2012 1403 1411
55. H. Naik, M. Vakilynejad, and J. Wu et al. Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of the GPR40 agonist TAK-875: results from a double-blind, placebo-controlled single oral dose rising study in healthy volunteers J Clin Pharmacol 52 2012 1007 1016
56. K. Kaku, T. Araki, and R. Yoshinaka Randomized, double-blind, dose-ranging study of TAK-875, a novel GPR40 agonist, in Japanese patients with inadequately controlled type 2 diabetes Diabetes Care 36 2013 245 250
57. T. Araki, M. Hirayama, S. Hiroi, and K. Kaku GPR40-induced insulin secretion by the novel agonist TAK-875: first clinical findings in patients with type 2 diabetes Diabetes Obes Metab 14 2012 271 278
58. X.L. Mo, H.K. Wei, J. Peng, and Y.X. Tao Free fatty acid receptor GPR120 and pathogenesis of obesity and type 2 diabetes mellitus Prog Mol Biol Transl Sci 114 2013 251 276
59. X.L. Mo, Z. Yang, and Y.X. Tao Targeting GPR119 for the potential treatment of type 2 diabetes mellitus Prog Mol Biol Transl Sci 121 2014 95 131
60. Y. Xiong, G. Swaminath, and Q. Cao et al. Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1 Mol Cell Endocrinol 369 2013 119 129
61. H. Yashiro, Y. Tsujihata, K. Takeuchi, M. Hazama, P.R. Johnson, and P. Rorsman The effects of TAK-875, a selective G protein-coupled receptor 40/free fatty acid 1 agonist, on insulin and glucagon secretion in isolated rat and human islets J Pharmacol Exp Ther 340 2012 483 489
62. T. Tomita, H. Masuzaki, and H. Iwakura et al. Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion Diabetologia 49 2006 962 968
63. T. Fujita, T. Matsuoka, T. Honda, K. Kabashima, T. Hirata, and S. Narumiya A GPR40 agonist GW9508 suppresses CCL5, CCL17, and CXCL10 induction in keratinocytes and attenuates cutaneous immune inflammation J Invest Dermatol 131 2011 1660 1667
64. T.S. Orchard, X.L. Pan, F. Cheek, S.W. Ing, and R.D. Jackson A systematic review of omega-3 fatty acids and osteoporosis Br J Nutr 107 2012 S253 S260
65. A. Grey, M. Bolland, and G. Gamble et al. The peroxisome proliferator-activated receptor-γ agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial J Clin Endocrinol Metab 92 2007 1305 1310
66. E.J. Whalen, S. Rajagopal, and R.J. Lefkowitz Therapeutic potential of β-arrestin- and G protein-biased agonists Trends Mol Med 17 2011 126 139
67. B.M. McGahon, D.S.D. Martin, D.F. Horrobin, and M.A. Lynch Age-related changes in synaptic function: analysis of the effect of dietary supplementation with ω-3 fatty acids Neuroscience 94 1999 305 314
68. T. Yamashima A putative link of PUFA, GPR40 and adult-born hippocampal neurons for memory Prog Neurobiol 84 2008 105 115
69. Y. Okaichi, Y. Ishikura, and K. Akimoto et al. Arachidonic acid improves aged rats' spatial cognition Physiol Behav 84 2005 617 623
70. C. He, X. Qu, L. Cui, J. Wang, and J.X. Kang Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid Proc Natl Acad Sci U S A 106 2009 11370 11375
71. J. Conquer, M. Tierney, J. Zecevic, W. Bettger, and R. Fisher Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment Lipids 35 2000 1305 1312
72. K. Nakamoto, T. Nishinaka, and K. Matsumoto et al. Involvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory system Brain Res 1432 2012 74 83
73. N.B. Boneva, and T. Yamashima New insights into "GPR40-CREB interaction in adult neurogenesis" specific for primates Hippocampus 22 2012 896 905
74. D. Ma, M. Zhang, and C.P. Larsen et al. DHA promotes the neuronal differentiation of rat neural stem cells transfected with GPR40 gene Brain Res 1330 2010 1 8
75. K. Nakamoto, and S. Tokuyama A long chain fatty acid receptor GPR40 as a novel pain control system Nihon Shinkei Seishin Yakurigaku Zasshi 32 2012 233 237
76. S. Hardy, W. El-Assaad, E. Przybytkowski, E. Joly, M. Prentki, and Y. Langelier Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells - a role for cardiolipin J Biol Chem 278 2003 31861 31870
77. S. Hardy, Y. Langelier, and M. Prentki Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects Cancer Res 60 2000 6353 6358
78. A. Soto-Guzman, T. Robledo, M. Lopez-Perez, and E.P. Salazar Oleic acid induces ERK1/2 activation and AP-1 DNA binding activity through a mechanism involving Src kinase and EGFR transactivation in breast cancer cells Mol Cell Endocrinol 294 2008 81 91
79. D. Gras, P. Chanez, V. Urbach, I. Vachier, P. Godard, and C. Bonnans Thiazolidinediones induce proliferation of human bronchial epithelial cells through the GPR40 receptor Am J Physiol Lung Cell Mol Physiol 296 2009 L970 L978
80. T. Kawai, and T. Fushiki Importance of lipolysis in oral cavity for orosensory detection of fat Am J Physiol Regul Integr Comp Physiol 285 2003 R447 R454
81. S. Matsumura, T. Mizushige, and T. Yoneda et al. GPR expression in the rat taste bud relating to fatty acid sensing Biomed Res 28 2007 49 55
82. C. Cartoni, K. Yasumatsu, and T. Ohkuri et al. Taste preference for fatty acids is mediated by GPR40 and GPR120 J Neurosci 30 2010 8376 8382
83. M.M. Galindo, N. Voigt, and J. Stein et al. G protein-coupled receptors in human fat taste perception Chem Senses 37 2012 123 139
84. G. Stewart, T. Hira, A. Higgins, C.P. Smith, and J.T. McLaughlin Mouse GPR40 heterologously expressed in Xenopus oocytes is activated by short-, medium-, and long-chain fatty acids Am J Physiol Cell Physiol 290 2006 C785 C792
85. 2 + signaling through activation of free fatty acid receptor GPR40 Neurobiol Dis 43 2011 465 472
86. G.V. Rayasam, V.K. Tulasi, and S. Sundaram et al. Identification of berberine as a novel agonist of fatty acid receptor GPR40 Phytother Res 24 2010 1260 1263
87. N. Negoro, S. Sasaki, and S. Mikami et al. Discovery of TAK-875: a potent, selective, and orally bioavailable GPR40 agonist ACS Med Chem Lett 1 2010 290 294
88. N. Gowda, A. Dandu, and J. Singh et al. Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats BMC Pharmacol Toxicol 14 2013 28
89. C. Zhou, C. Tang, and E. Chang et al. Discovery of 5-aryloxy-2,4- thiazolidinediones as potent GPR40 agonists Bioorg Med Chem Lett 20 2010 1298 1301
90. J. Schmidt, K. Liebscher, and N. Merten et al. Conjugated linoleic acids mediate insulin release through islet G protein-coupled receptor FFA1/GPR40 J Biol Chem 286 2011 11890 11894
91. H. Hu, L.Y. He, and Z. Gong et al. A novel class of antagonists for the FFAs receptor GPR40 Biochem Biophys Res Commun 390 2009 557 563
92. P.S. Humphries, J.W. Benbow, and P.D. Bonin et al. Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists Bioorg Med Chem Lett 19 2009 2400 2403
93. T. Hara, A. Hirasawa, and Q. Sun et al. Flow cytometry-based binding assay for GPR40 (FFAR1; free fatty acid receptor 1) Mol Pharmacol 75 2009 85 91
94. D.C. Lin, Q. Guo, and J. Luo et al. Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptor Mol Pharmacol 82 2012 843 859
95. C.S. Sum, I.G. Tikhonova, and S. Neumann et al. Identification of residues important for agonist recognition and activation in GPR40 J Biol Chem 282 2007 29248 29255
96. I.G. Tikhonova, C.S. Sum, and S. Neumann et al. Bidirectional, iterative approach to the structural delineation of the functional "chemoprint" in GPR40 for agonist recognition J Med Chem 50 2007 2981 2989
97. C.S. Sum, I.G. Tikhonova, S. Costanzi, and M.C. Gershengorn Two arginine-glutamate ionic locks near the extracellular surface of FFAR1 gate receptor activation J Biol Chem 284 2009 3529 3536
98. M. Ferdaoussi, V. Bergeron, and B. Zarrouki et al. G protein-coupled receptor (GPR)40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1 Diabetologia 55 2012 2682 2692
99. A.D. Mancini, and V. Poitout The fatty acid receptor FFA1/GPR40 a decade later: how much do we know? Trends Endocrinol Metab 24 2013 398 407
100. 35S]thio)triphosphate binding studies reflects binding of an endogenous agonist Mol Pharmacol 71 2007 994 1005
101. Y.H. Hamid, H. Vissing, and B. Holst et al. Studies of relationships between variation of the human G protein-coupled receptor 40 gene and type 2 diabetes and insulin release Diabet Med 22 2005 74 80
102. T. Ogawa, H. Hirose, K. Miyashita, I. Saito, and T. Saruta GPR40 gene Arg211His polymorphism may contribute to the variation of insulin secretory capacity in Japanese men Metabolism 54 2005 296 299
103. H. Haga, R. Yamada, Y. Ohnishi, Y. Nakamura, and T. Tanaka Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190562 genetic variations in the human genome J Hum Genet 47 2002 605 610
104. R. Vettor, M. Granzotto, and D. De Stefani et al. Loss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilization J Clin Endocrinol Metab 93 2008 3541 3550
105. Y.X. Tao, Z.H. Yuan, and J. Xie G protein-coupled receptors as regulators of energy homeostasis Prog Mol Biol Transl Sci 114 2013 1 43
106. Y.X. Tao, and X.F. Liang G protein-coupled receptors as regulators of glucose homeostasis Prog Mol Biol Transl Sci 121 2014 1 21